Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-572-0 | CAS number: 827-52-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Recent and very well documented study with complete information in accordance with OECD and GLP guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Remarks:
- There were 8 deviations that had been report but this deviations are not considered to have had an adverse impact on the integrity of the study.
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- Hypoxanthine-guanine phosphoribosyl transferase (HPRT) locus
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- CHO cells were maintained in Ham's F1 medium supplemented with L-glutamine and 5% heat-inactivated and dialyzed fetal bovine serium (F12CM5) under standard conditions (37+/-1°C in a humidified atmosphere of 5+/-1% CO2 in air). Hypoxanthine-free F12CM5 (Hx F12CM5) was used for mutant selection. Medium for selection of mutants also contained 10 µM TG. All media contained antimycotics and antibiotics.
To reduce the frequency of spontaneous HPRT mutations prior to use in an assay, the cells were cleansed in medium supplemented with hypoxanthine, aminoterpin and thymidine (HAT), prior to freezing. Cells used in the mutation assay did not exceed four passages from the frozen stock. - Metabolic activation:
- with and without
- Metabolic activation system:
- S9
- Test concentrations with justification for top dose:
- Preliminary test:
3.13, 6.25, 12.5, 25.0, 50.0, 100, 200, 400, 800, 1600 µg/mL with and without S9
Definitive mutagenicity assay:
6.25, 12.5, 25.0, 50.0, 100, 125 µg/mL with S9
0.781, 1.56, 3.13, 6.25, 12.5, 15.0, 20.0 µg/mL without S9
Independent confirmatory assay:
12.5, 25.0, 50.0, 60.0, 80.0, 100, 125 µg/mL with S9
1.56, 3.13, 6.25, 12.5, 15.0, 20.0, 25.0 µg/mL without S9 - Vehicle / solvent:
- Test article was diluted for use in dimethyl sulfoxide (DMSO; CAS No. 67-68-5; lot No. MKBF8188V with a purity of 99.98% and an expiration of July 2014; Lot No.SHBC3749V purity of 99.92% and an expiration of April 2016) obtained from Sigma-Aldricht.
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- ethylmethanesulphonate
- Details on test system and experimental conditions:
- The assay was conducted by exposing CHO cells to appropriate concentrations of the test articleas well as the concurrent positive and vehicule controls, in the presence and absence of an exogenous metabolic activation system.
- Evaluation criteria:
- The test article was considered to have produced a positive response if it induced a statistically significant and dose-dependant increase in mutant
frequency (p<0.05) representing an increase of >15TG mutant/1000 000 clonable cells over the concurrent vehicule controls.
If only one criterion was met, the result was considered equivocal. If neither criterion is met, the results were considered to be negative. - Statistics:
- Statistical analyses were performed using the method of See and Irr (1981), with a significance established at the 0.05 level.
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 125.0µg/ml with S9 and 25.0µg/ml without S9
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
The results indicate that phenylcyclohexane was negative in the In vitro Mammialan Cell Forward Gene Mutation (CHO/HPRT) Assay with Duplicate Cultures under the conditions of the test and acording to the criteria of the test protocol. - Executive summary:
This study evaluates the ability of phenylcyclohexane to induce forwards mutation at the HPRT locus of CHO cells in presence and absence of S9 (an exogenous metabolic activation system), and in presence of 6 -TG (6- thioguanine).
Seven or eight dose levels were tested based on the cytotoxicity profile of the test article but only five concentrations were carried through the entire assay and evaluation. All test and control articles and concentrations were evaluated in duplicate cultures. Cells were treated for 5 hours in the presence and absence of S9, by addition of the test and control (Benzo(a)pyrene and ethyl methanesulfate) article formulations to the treatment medium. At the end of the experiment the cells were fixed and counted. Mutant frequency were expressed as the number of TG mutant/1 000 000 clonable cells.
The following evaluation criteria were adopted: If the test article induced an increase of more than 15 TG mutant/ 1 000 000 clonable cells in compare with the vehicle controls, the test article was considered to have produced a positive response.
The results of this experiment showed no significant increase in mutant frequency, as compared to the concurrent vehicule controls at any of the evaluated concentrations with and without S9, whereas the positive control did induce a significant increases in mutant frequency. These results were confirmed in an independent confirmatory assay.
In conclusion, the results indicate that phenylcyclohexane does not induce mutagenicity on CHO/HPRT cells under the applied test conditions.
Reference
Definitive mutagenicity assay
The average adjusted relative survivals at concentrations of 100 µg/mL with S9 and 20.0 µg/mL without S9 were 76.9 and 16.2%, respectively. No significant increase in mutant frequency, as compared to the concurrent vehicle controls, were observed at any concentration evaluated with or without S9 (p > 0.05). In contrast, the positive controls induced significant increases in mutant frequency (p < 0.01).
Independent confirmatory assay:
The average adjusted relative survivals at concentrations of 125µg/mL with S9 and 25.0 µg/mL without S9 were 9.7 and 21.9%, respectively. No significant increase in mutant frequency, as compared to the concurrent vehicle controls, were observed at any concentration evaluated with or without S9 (p > 0.05). In contrast, the positive controls induced significant increases in mutant frequency (p < 0.01).
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
In total 3 studies are available that assess the in vitro genotoxicity of cyclohexylbenzene. Cyclohexylbenzene did not induce genotoxic responses in any of the tests.
Bacterial reverse mutation
The first study (Bowles, 2001) is a well-documented Ames test that is carried out according to GLP and OECD guidelines. In this test,Salmonella typhimuriumstrains TA1535, TA1537, TA98, TA100 and Escherichia coli strain WP2 uvrA were treated with the test material using the Ames plate incorporation method at up to 6 dose levels, in triplicate, both with and without the addition of a rat liver homogenate metabolising system (10% liver S9 in standard co-factors). The test material caused a visible reduction in the growth of the bacterial background lawn to all of the Salmonella tester strains, initially at 500 and 1500 μg/plate, without and with S9 -mix respectively. No toxicity was observed in E. coli tester strain WP2 uvrA. The test material was, therefore, tested up to the maximum recommended dose level of 5000 μg/plate. No test material precipitate was observed on the plates at any of the doses tested in either the presence or absence of S9 -mix. No significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test material, either with or without metabolic activation.
Chromosome aberration
The second study (Wright, 2001) assessed the potential chromosomal mutagenicity of cyclohexylbenzene on the metaphase chromosomes of the Chinese Hamster Lung (CHL) cell line according to the requirements of the Japanese New Chemical Substance Law (METI), OECD 473 and the updated Annex V B10 Method. Duplicate cultures of CHL cells were treated with the test material at several dose levels, together with vehicle and positive controls. Five exposure groups were used: Experiment 1 included a 6(18)-hour exposure, both with and without the addition of an induced rat liver homogenate metabolising system, Experiment 2 included a 24 -h continuous exposure, a 48 h continuous exposure and a repeat of the 6(18) h exposure with metabolic activation. The dose levels evaluated in the main experiments were selected from a range of dose levels based on the results of a preliminary toxicity test and were in the range of 3.125 to 25 μg/ml for the 6(18)-h exposure without S9, 6.25 to 100 μg/ml for the 24 and 48 h treatments. The vehicle (solvent) controls gave frequencies of cells with aberrations within the range expected for the CHL cell line. All the positive control chemicals induced highly significant increases in the frequency of cells with aberrations indicating the satisfactory performance of the test and of the activity of the metabolising system. The test material did not induce any significant increases in the frequency of cells with aberrations in any of the exposure groups. The test material was shown to be toxic to CHL cells in vitro and optimal levels of toxicity were achieved in all exposure groups.
Gene mutation
The third study (Stankoweski, 2013) evaluates the ability of cyclohexylbenzene to induce forwards mutation at the HPRT locus of CHO cells in presence and absence of S9 (an exogenous metabolic activation system), and in presence of 6 -TG (6- thioguanine). Seven or eight dose levels were tested based on the cytotoxicity profile of the test article but only five concentrations were carried through the entire assay and evaluation. All test and control articles and concentrations were evaluated in duplicate cultures. Cells were treated for 5 hours in the presence and absence of S9, by addition of the test and control (Benzo(a)pyrene and ethyl methanesulfate) article formulations to the treatment medium. At the end of the experiment the cells were fixed and counted. Mutant frequency were expressed as the number of TG mutant/1 000 000 clonable cells. The following evaluation criteria were adopted: If the test article induced an increase of more than 15 TG mutant/ 1 000 000 clonable cells in compare with the vehicle controls, the test article was considered to have produced a positive response. The results of this experiment showed no significant increase in mutant frequency, as compared to the concurrent vehicule controls at any of the evaluated concentrations with and without S9, whereas the positive control did induce a significant increases in mutant frequency. These results were confirmed in an independent confirmatory assay. In conclusion, the results indicate that phenylcyclohexane does not induce mutagenicity on CHO/HPRT cells under the applied test conditions.
Justification for selection of genetic toxicity endpoint
For the endpoint on genetic toxicity, 3 types of tests are required: Ames, gene mutation and chromosome aberration. Therefore, all 3 studies available in this endpoint are of equal importance.
Justification for classification or non-classification
As no genotoxic effects are observed in the available studies addressing the different endpoint of genetic toxicity, classification for genetic toxicity under EU Regulation No. 1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures (CLP) and/or under Council Directive 67/548/EEC on the Classification, Packaging and Labelling of Dangerous substances (DSD) is not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.